Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Matos

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
BMC Plant Biology|November 19, 2008
Assessment of allelic diversity in intron-containing Mal d 1 genes and their association to apple allergenicityZhongshan Gao, Eric W van de Weg, Catarina I Matos, et al.
Circulation|January 24, 2013
Duration of cardiopulmonary resuscitation and illness category impact survival and neurologic outcomes for in-hospital pediatric cardiac arrestsRenée I Matos, R Scott Watson, Vinay M Nadkarni, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 23, 2015
A Three-Component Assembly Promoted by Boronic Acids Delivers a Modular Fluorophore Platform (BASHY Dyes)Fábio M F Santos, João N Rosa, Nuno R Candeias, et al.
Journal of Veterinary Internal Medicine|February 26, 2026
Development and evaluation of a composite echocardiographic score for predicting pulmonary hypertension severity in dogsWei-Tao Chang, Laín García-Guasch, I-Ping Chan, et al.
Frontiers in Pediatrics|August 15, 2014
Existing data analysis in pediatric critical care researchTellen D Bennett, Michael C Spaeder, Renée I Matos, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 22, 2019
Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancerAna I Matos, Barbara Carreira, Carina Peres, et al.
Human Immunology|April 18, 2012
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: importance in ARDS in septic pediatric critically ill patientsZ M Azevedo, D B Moore, F C Lima, et al.
Advanced Healthcare Materials|August 29, 2024
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast CancerCláudio Ferro, Ana I Matos, Luigia Serpico, et al.
ESMO Open|April 9, 2022
Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumorsS Ochsenreither, W M Fiedler, G D Conte, et al.
ESMO Open|July 16, 2022
Erratum to 'Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody Gatipotuzumab with the anti-EGFR Tomuzotuximab in patients with refractory solid tumors': [ESMO Open Volume 7, Issue 2, April 2022, 100447]S Ochsenreither, W M Fiedler, G Del Conte, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
BMC Plant Biology|November 19, 2008
Assessment of allelic diversity in intron-containing Mal d 1 genes and their association to apple allergenicityZhongshan Gao, Eric W van de Weg, Catarina I Matos, et al.
Circulation|January 24, 2013
Duration of cardiopulmonary resuscitation and illness category impact survival and neurologic outcomes for in-hospital pediatric cardiac arrestsRenée I Matos, R Scott Watson, Vinay M Nadkarni, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 23, 2015
A Three-Component Assembly Promoted by Boronic Acids Delivers a Modular Fluorophore Platform (BASHY Dyes)Fábio M F Santos, João N Rosa, Nuno R Candeias, et al.
Journal of Veterinary Internal Medicine|February 26, 2026
Development and evaluation of a composite echocardiographic score for predicting pulmonary hypertension severity in dogsWei-Tao Chang, Laín García-Guasch, I-Ping Chan, et al.
Frontiers in Pediatrics|August 15, 2014
Existing data analysis in pediatric critical care researchTellen D Bennett, Michael C Spaeder, Renée I Matos, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 22, 2019
Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancerAna I Matos, Barbara Carreira, Carina Peres, et al.
Human Immunology|April 18, 2012
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: importance in ARDS in septic pediatric critically ill patientsZ M Azevedo, D B Moore, F C Lima, et al.
Advanced Healthcare Materials|August 29, 2024
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast CancerCláudio Ferro, Ana I Matos, Luigia Serpico, et al.
ESMO Open|April 9, 2022
Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumorsS Ochsenreither, W M Fiedler, G D Conte, et al.
ESMO Open|July 16, 2022
Erratum to 'Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody Gatipotuzumab with the anti-EGFR Tomuzotuximab in patients with refractory solid tumors': [ESMO Open Volume 7, Issue 2, April 2022, 100447]S Ochsenreither, W M Fiedler, G Del Conte, et al.
Pageof 10